04.27.12
In 2007, Chemi Nutra, White Bear Lake, MN, and Increnovo, Milwaukee, WI, began a collaboration involving discovery and investigation into phosphatidylserine’s (PS) ability to influence cortisol and testosterone levels in exercising and non-exercising men. As a result of these discoveries and subsequent patent filing, the two companies have formally announced their patent “Methods using phosphatidylserine, lysophosphatidylserine, and/or salts thereof to increase testosterone levels” (US Patent No. 8,124,594). Specifically, the patent describes the oral use of PS to maintain healthy testosterone levels, targeted toward men experiencing age-related declines in testosterone, exercise induced declines in testosterone and/or hypogonadism.
